BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38831883)

  • 1. Better together: nanoscale co-delivery systems of therapeutic agents for high-performance cancer therapy.
    Sun L; Li Z; Lan J; Wu Y; Zhang T; Ding Y
    Front Pharmacol; 2024; 15():1389922. PubMed ID: 38831883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional co-transport carriers based on cyclodextrin assembly for cancer synergistic therapy.
    Yi S; Liao R; Zhao W; Huang Y; He Y
    Theranostics; 2022; 12(6):2560-2579. PubMed ID: 35401819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review.
    Zhou L; Li Y; Liang Q; Liu J; Liu Y
    J Drug Target; 2022 Jul; 30(6):577-588. PubMed ID: 35179094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery systems for differential release in combination therapy.
    Zhang H; Wang G; Yang H
    Expert Opin Drug Deliv; 2011 Feb; 8(2):171-90. PubMed ID: 21226651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
    Gautam RK; Mittal P; Goyal R; Dua K; Mishra DK; Sharma S; Singla RK
    Curr Med Chem; 2023 Oct; ():. PubMed ID: 37828674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial Drug Delivery Systems for Cancer Therapy: "Why" and "How".
    Zhao X; Xie N; Zhang H; Zhou W; Ding J
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
    Majumder J; Minko T
    Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.
    Liboiron BD; Mayer LD
    Ther Deliv; 2014 Feb; 5(2):149-71. PubMed ID: 24483194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
    Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
    Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome-based drug co-delivery systems in cancer cells.
    Zununi Vahed S; Salehi R; Davaran S; Sharifi S
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():1327-1341. PubMed ID: 27987688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery systems: hope for clinical application?
    Nezhadi S; Dorkoosh FA
    Drug Deliv Transl Res; 2022 Jun; 12(6):1339-1354. PubMed ID: 34402023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of exosomes as nanocarriers in cancer therapy.
    Hu J; Zhu J; Chai J; Zhao Y; Luan J; Wang Y
    J Mater Chem B; 2023 Nov; 11(44):10595-10612. PubMed ID: 37927220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-Drug Delivery Systems in Oral Cancer Therapy: Recent Developments and Prospective.
    Zhang Y; Wu Y; Du H; Li Z; Bai X; Wu Y; Li H; Zhou M; Cao Y; Chen X
    Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38276483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle drug delivery systems for synergistic delivery of tumor therapy.
    Chen D; Liu X; Lu X; Tian J
    Front Pharmacol; 2023; 14():1111991. PubMed ID: 36874010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancements in nanoscale delivery systems: optimizing intermolecular interactions for superior drug encapsulation and precision release.
    Dong E; Huo Q; Zhang J; Han H; Cai T; Liu D
    Drug Deliv Transl Res; 2024 Apr; ():. PubMed ID: 38573495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.